After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Regulus Therapeutics Inc is $129.17M. A total of 0.56 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Hagan Joseph P bought 50,000 shares of RGLS for 1.09 per share on Jan 30 ’25. After the transaction, the Chief Executive Officer now owns 260,808 company shares. In a previous transaction on Jan 30 ’25, BALTIMORE DAVID bought 19,610 shares at 1.06 per share. RGLS shares that Director owns now total 22,169.
Among the insiders who sold shares, Aker Christopher Ray disposed of 38,547 shares on Jan 13 ’25 at a per-share price of $1.26. This resulted in the Sr. VP & General Counsel holding 54,634 shares of RGLS after the transaction. In another insider transaction, Aker Christopher Ray sold 5,088 shares at $1.26 per share on Jan 14 ’25. Company shares held by the Sr. VP & General Counsel now total 49,546.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RGLS has a high of $2.90 and a low of $0.83.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RGLS’s latest balance sheet shows that the firm has $60.38M in Cash & Short Term Investments as of fiscal 2021. There were $7.09M in debt and $5.23M in liabilities at the time. Its Book Value Per Share was $1.17, while its Total Shareholder’s Equity was $54.96M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RGLS is Buy with a score of 5.00.
